<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35452507</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1540-7748</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>154</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Sep</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of general physiology</Title>
          <ISOAbbreviation>J Gen Physiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Heart failure in mice induces a dysfunction of the sinus node associated with reduced CaMKII signaling.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e202112895</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1085/jgp.202112895</ELocationID>
        <Abstract>
          <AbstractText>Dysfunction of the sinoatrial node (SAN), the natural heart pacemaker, is common in heart failure (HF) patients. SAN spontaneous activity relies on various ion currents in the plasma membrane (voltage clock), but intracellular Ca2+ ([Ca2+]i) release via ryanodine receptor 2 (RYR2; Ca2+ clock) plays an important synergetic role. Whereas remodeling of voltage-clock components has been revealed in HF, less is known about possible alterations to the Ca2+ clock. Here, we analyzed [Ca2+]i handling in SAN from a mouse HF model after transverse aortic constriction (TAC) and compared it with sham-operated animals. ECG data from awake animals showed slower heart rate in HF mice upon autonomic nervous system blockade, indicating intrinsic sinus node dysfunction. Confocal microscopy analyses of SAN cells within whole tissue showed slower and less frequent [Ca2+]i transients in HF. This correlated with fewer and smaller spontaneous Ca2+ sparks in HF SAN cells, which associated with lower RYR2 protein expression level and reduced phosphorylation at the CaMKII site. Moreover, PLB phosphorylation at the CaMKII site was also decreased in HF, which could lead to reduced sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) function and lower sarcoplasmic reticulum Ca2+ content, further depressing the Ca2+ clock. The inhibition of CaMKII with KN93 slowed [Ca2+]i transient rate in both groups, but this effect was smaller in HF SAN, consistent with less CaMKII activation. In conclusion, our data uncover that the mechanism of intrinsic pacemaker dysfunction in HF involves reduced CaMKII activation.</AbstractText>
          <CopyrightInformation>© 2022 Xue et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xue</LastName>
            <ForeName>Jian-Bin</ForeName>
            <Initials>JB</Initials>
            <Identifier Source="ORCID">0000-0003-3742-3982</Identifier>
            <AffiliationInfo>
              <Affiliation>Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Val-Blasco</LastName>
            <ForeName>Almudena</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Davoodi</LastName>
            <ForeName>Moran</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Engineering, Technion Institute, Haifa, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gómez</LastName>
            <ForeName>Susana</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yaniv</LastName>
            <ForeName>Yael</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0002-5183-6284</Identifier>
            <AffiliationInfo>
              <Affiliation>Biomedical Engineering, Technion Institute, Haifa, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Benitah</LastName>
            <ForeName>Jean-Pierre</ForeName>
            <Initials>JP</Initials>
            <Identifier Source="ORCID">0000-0002-9866-9081</Identifier>
            <AffiliationInfo>
              <Affiliation>Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gómez</LastName>
            <ForeName>Ana María</ForeName>
            <Initials>AM</Initials>
            <Identifier Source="ORCID">0000-0003-0009-2884</Identifier>
            <AffiliationInfo>
              <Affiliation>Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Université Paris-Saclay, INSERM, Châtenay-Malabry, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>2R01HL055438-22</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 HL055438</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Gen Physiol</MedlineTA>
        <NlmUniqueID>2985110R</NlmUniqueID>
        <ISSNLinking>0022-1295</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019837">Ryanodine Receptor Calcium Release Channel</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.17</RegistryNumber>
          <NameOfSubstance UI="D054732">Calcium-Calmodulin-Dependent Protein Kinase Type 2</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>SY7Q814VUP</RegistryNumber>
          <NameOfSubstance UI="D002118">Calcium</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054732" MajorTopicYN="Y">Calcium-Calmodulin-Dependent Protein Kinase Type 2</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019837" MajorTopicYN="N">Ryanodine Receptor Calcium Release Channel</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012519" MajorTopicYN="N">Sarcoplasmic Reticulum</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012849" MajorTopicYN="N">Sinoatrial Node</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>3</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>17</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35452507</ArticleId>
        <ArticleId IdType="pmc">PMC9040062</ArticleId>
        <ArticleId IdType="doi">10.1085/jgp.202112895</ArticleId>
        <ArticleId IdType="pii">213178</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Alboni, P., Menozzi C., Brignole M., Paparella N., Gaggioli G., Lolli G., and Cappato R.. 1997. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: A randomized controlled trial. Circulation. 96:260–266. 10.1161/01.cir.96.1.260</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.cir.96.1.260</ArticleId>
            <ArticleId IdType="pubmed">9236443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson, M.E., Brown J.H., and Bers D.M.. 2011. CaMKII in myocardial hypertrophy and heart failure. J. Mol. Cell. Cardiol.
51:468–473. 10.1016/j.yjmcc.2011.01.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yjmcc.2011.01.012</ArticleId>
            <ArticleId IdType="pmc">PMC3158288</ArticleId>
            <ArticleId IdType="pubmed">21276796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Backs, J., and Olson E.N.. 2006. Control of cardiac growth by histone acetylation/deacetylation. Circ. Res.
98:15–24. 10.1161/01.res.0000197782.21444.8f</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.res.0000197782.21444.8f</ArticleId>
            <ArticleId IdType="pubmed">16397154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behar, J.A., Rosenberg A.A., Weiser-Bitoun I., Shemla O., Alexandrovich A., Konyukhov E., and Yaniv Y.. 2018. PhysioZoo: A novel open access platform for heart rate variability analysis of mammalian electrocardiographic data. Front. Physiol.
9:1390. 10.3389/fphys.2018.01390</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2018.01390</ArticleId>
            <ArticleId IdType="pmc">PMC6180147</ArticleId>
            <ArticleId IdType="pubmed">30337883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benes, J., Kotrc M., Borlaug B.A., Lefflerova K., Jarolim P., Bendlova B., Jabor A., Kautzner J., and Melenovsky V.. 2013. Resting heart rate and heart rate reserve in advanced heart failure have distinct pathophysiologic correlates and prognostic impact: A prospective pilot study. JACC Heart Fail.
1:259–266. 10.1016/j.jchf.2013.03.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jchf.2013.03.008</ArticleId>
            <ArticleId IdType="pubmed">24621878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bogdanov, K.Y., Vinogradova T.M., and Lakatta E.G.. 2001. Sinoatrial nodal cell ryanodine receptor and Na+-Ca2+ exchanger: Molecular partners in pacemaker regulation. Circ. Res.
88:1254–1258. 10.1161/hh1201.092095</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/hh1201.092095</ArticleId>
            <ArticleId IdType="pubmed">11420301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brubaker, P.H., Joo K.C., Stewart K.P., Fray B., Moore B., and Kitzman D.W.. 2006. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J. Cardiopulm. Rehabil.
26:86–89. 10.1097/00008483-200603000-00007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00008483-200603000-00007</ArticleId>
            <ArticleId IdType="pubmed">16569976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cesarovic, N., Jirkof P., Rettich A., and Arras M.. 2011. Implantation of radiotelemetry transmitters yielding data on ECG, heart rate, core body temperature and activity in free-moving laboratory mice. J. Vis. Exp.
3260. 10.3791/3260</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3791/3260</ArticleId>
            <ArticleId IdType="pmc">PMC3308592</ArticleId>
            <ArticleId IdType="pubmed">22126906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan, C.S., Lin Y.K., Chen Y.C., Lu Y.Y., Chen S.A., and Chen Y.J.. 2019. Heart failure differentially modulates natural (sinoatrial node) and ectopic (pulmonary veins) pacemakers: Mechanism and therapeutic implication for atrial fibrillation. Int. J. Mol. Sci.
20:3224. 10.3390/ijms20133224</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20133224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang, S.L., Chuang H.L., Chen Y.C., Kao Y.H., Lin Y.K., Yeh Y.H., Chen S.A., and Chen Y.J.. 2017. Heart failure modulates electropharmacological characteristics of sinoatrial nodes. Exp. Ther. Med.
13:771–779. 10.3892/etm.2016.4015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/etm.2016.4015</ArticleId>
            <ArticleId IdType="pmc">PMC5348682</ArticleId>
            <ArticleId IdType="pubmed">28352365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen, Y., Escoubet B., Prunier F., Amour J., Simonides W.S., Vivien B., Lenoir C., Heimburger M., Choqueux C., Gellen B., et al. . 2004. Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias. Circulation. 109:1898–1903. 10.1161/01.cir.0000124230.60028.42</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.cir.0000124230.60028.42</ArticleId>
            <ArticleId IdType="pubmed">15037529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curran, J., Brown K.H., Santiago D.J., Pogwizd S., Bers D.M., and Shannon T.R.. 2010. Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca2+-calmodulin-dependent protein kinase II. J. Mol. Cell. Cardiol.
49:25–32. 10.1016/j.yjmcc.2010.03.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yjmcc.2010.03.013</ArticleId>
            <ArticleId IdType="pmc">PMC2883657</ArticleId>
            <ArticleId IdType="pubmed">20353795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Del Buono, M.G., Arena R., Borlaug B.A., Carbone S., Canada J.M., Kirkman D.L., Garten R., Rodriguez-Miguelez P., Guazzi M., Lavie C.J., and Abbate A.. 2019. Exercise intolerance in patients with heart failure. JACC state-of-the-art review. J. Am. Coll. Cardiol.
73:2209–2225. 10.1016/j.jacc.2019.01.072</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2019.01.072</ArticleId>
            <ArticleId IdType="pubmed">31047010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dobrzynski, H., Boyett M.R., and Anderson R.H.. 2007. New insights into pacemaker activity: Promoting understanding of sick sinus syndrome. Circulation. 115:1921–1932. 10.1161/CIRCULATIONAHA.106.616011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.616011</ArticleId>
            <ArticleId IdType="pubmed">17420362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du, Y., Huang X., Wang T., Han K., Zhang J., Xi Y., Wu G., and Ma A.. 2007. Downregulation of neuronal sodium channel subunits Nav1.1 and Nav1.6 in the sinoatrial node from volume-overloaded heart failure rat. Pflugers Arch.
454:451–459. 10.1007/s00424-007s0040216-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00424-007s0040216-4</ArticleId>
            <ArticleId IdType="pubmed">17273863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eisner, D.A., Caldwell J.L., Kistamas K., and Trafford A.W.. 2017. Calcium and excitation-contraction coupling in the heart. Circ. Res.
121:181–195. 10.1161/CIRCRESAHA.117.310230</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.117.310230</ArticleId>
            <ArticleId IdType="pmc">PMC5497788</ArticleId>
            <ArticleId IdType="pubmed">28684623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faggiano, P., d’ Aloia A., Gualeni A., Gardini A., and Giordano A.. 2001. Mechanisms and immediate outcome of in-hospital cardiac arrest in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol.
87:655–657. 10.1016/s0002-9149(00)01450-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0002-9149(00)01450-8</ArticleId>
            <ArticleId IdType="pubmed">11230859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrero, P., Said M., Sanchez G., Vittone L., Valverde C., Donoso P., Mattiazzi A., and Mundina-Weilenmann C.. 2007. Ca2+/calmodulin kinase II increases ryanodine binding and Ca2+-induced sarcoplasmic reticulum Ca2+ release kinetics during beta-adrenergic stimulation. J. Mol. Cell Cardiol. 43:281–291. 10.1016/j.yjmcc.2007.05.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yjmcc.2007.05.022</ArticleId>
            <ArticleId IdType="pmc">PMC2045504</ArticleId>
            <ArticleId IdType="pubmed">17643448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furihata, T., Kinugawa S., Takada S., Fukushima A., Takahashi M., Homma T., Masaki Y., Tsuda M., Matsumoto J., Mizushima W., et al. . 2016. The experimental model of transition from compensated cardiac hypertrophy to failure created by transverse aortic constriction in mice. Int. J. Cardiol. Heart Vasc.
11:24–28. 10.1016/j.ijcha.2016.03.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcha.2016.03.007</ArticleId>
            <ArticleId IdType="pmc">PMC5441312</ArticleId>
            <ArticleId IdType="pubmed">28616522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gómez, A.M., Valdivia H.H., Cheng H., Lederer M.R., Santana L.F., Cannell M.B., McCune S.A., Altschuld R.A., and Lederer W.J.. 1997. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 276:800–806. 10.1126/science.276.5313.800</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.276.5313.800</ArticleId>
            <ArticleId IdType="pubmed">9115206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo, A., Zhang C., Wei S., Chen B., and Song L.S.. 2013. Emerging mechanisms of T-tubule remodelling in heart failure. Cardiovasc. Res.
98:204–215. 10.1093/cvr/cvt020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cvr/cvt020</ArticleId>
            <ArticleId IdType="pmc">PMC3697065</ArticleId>
            <ArticleId IdType="pubmed">23393229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higginbotham, M.B., Morris K.G., Conn E.H., Coleman R.E., and Cobb F.R.. 1983. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am. J. Cardiol.
51:52–60. 10.1016/s0002-9149(83)80010-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0002-9149(83)80010-1</ArticleId>
            <ArticleId IdType="pubmed">6849267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janse, M.J.
2004. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc. Res.
61:208–217. 10.1016/j.cardiores.2003.11.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cardiores.2003.11.018</ArticleId>
            <ArticleId IdType="pubmed">14736537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jose, A.D., and Collison D.. 1970. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc. Res.
4:160–167. 10.1093/cvr/4.2.160</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cvr/4.2.160</ArticleId>
            <ArticleId IdType="pubmed">4192616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jose, A.D., and Taylor R.R.. 1969. Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J. Clin. Invest.
48:2019–2031. 10.1172/JCI106167</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI106167</ArticleId>
            <ArticleId IdType="pmc">PMC297454</ArticleId>
            <ArticleId IdType="pubmed">5398888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kannel, W.B.
2000. Incidence and epidemiology of heart failure. Heart Fail. Rev.
5:167–173. 10.1023/A:1009884820941</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1009884820941</ArticleId>
            <ArticleId IdType="pubmed">16228142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuwabara, Y., Kuwahara K., Takano M., Kinoshita H., Arai Y., Yasuno S., Nakagawa Y., Igata S., Usami S., Minami T., et al. . 2013. Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts. J. Am. Heart Assoc.
2:e000150. 10.1161/JAHA.113.000150</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.113.000150</ArticleId>
            <ArticleId IdType="pmc">PMC3698776</ArticleId>
            <ArticleId IdType="pubmed">23709563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lakatta, E.G., and DiFrancesco D.. 2009. What keeps us ticking: A funny current, a calcium clock, or both?
J. Mol. Cell Cardiol.
47:157–170. 10.1016/j.yjmcc.2009.03.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yjmcc.2009.03.022</ArticleId>
            <ArticleId IdType="pmc">PMC4554526</ArticleId>
            <ArticleId IdType="pubmed">19361514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lakatta, E.G., Maltsev V.A., and Vinogradova T.M.. 2010. A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart’s pacemaker. Circ. Res.
106:659–673. 10.1161/CIRCRESAHA.109.206078</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.109.206078</ArticleId>
            <ArticleId IdType="pmc">PMC2837285</ArticleId>
            <ArticleId IdType="pubmed">20203315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li, Y., Sirenko S., Riordon D.R., Yang D., Spurgeon H., Lakatta E.G., and Vinogradova T.M.. 2016. CaMKII-dependent phosphorylation regulates basal cardiac pacemaker function via modulation of local Ca2+ releases. Am. J. Physiol. Heart Circ. Physiol.
311:H532–H544. 10.1152/ajpheart.00765.2015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00765.2015</ArticleId>
            <ArticleId IdType="pmc">PMC5142178</ArticleId>
            <ArticleId IdType="pubmed">27402669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipskaia, L., Chemaly E.R., Hadri L., Lompre A.M., and Hajjar R.J.. 2010. Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic target for heart failure. Expert Opin. Biol. Ther.
10:29–41. 10.1517/14712590903321462</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14712590903321462</ArticleId>
            <ArticleId IdType="pmc">PMC3001226</ArticleId>
            <ArticleId IdType="pubmed">20078230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Logantha, S.J.R.J., Stokke M.K., Atkinson A.J., Kharche S.R., Parveen S., Saeed Y., Sjaastad I., Sejersted O.M., and Dobrzynski H.. 2016. Ca2+-clock-dependent pacemaking in the sinus node is impaired in mice with a cardiac specific reduction in SERCA2 abundance. Front. Physiol.
7:197. 10.3389/fphys.2016.00197</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2016.00197</ArticleId>
            <ArticleId IdType="pmc">PMC4889599</ArticleId>
            <ArticleId IdType="pubmed">27313537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo, M., and Anderson M.E.. 2013. Mechanisms of altered Ca2+ handling in heart failure. Circ. Res.
113:690–708. 10.1161/circresaha.113.301651</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/circresaha.113.301651</ArticleId>
            <ArticleId IdType="pmc">PMC4080816</ArticleId>
            <ArticleId IdType="pubmed">23989713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luu, M., Stevenson W.G., Stevenson L.W., Baron K., and Walden J.. 1989. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 80:1675–1680. 10.1161/01.cir.80.6.1675</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.cir.80.6.1675</ArticleId>
            <ArticleId IdType="pubmed">2598430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maltsev, V.A., Vinogradova T.M., and Lakatta E.G.. 2006. The emergence of a general theory of the initiation and strength of the heartbeat. J. Pharmacol. Sci.
100:338–369. 10.1254/jphs.cr0060018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1254/jphs.cr0060018</ArticleId>
            <ArticleId IdType="pubmed">16799255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishida, K., Otsu K., Hori M., Kuzuya T., and Tada M.. 1996. Cloning and characterization of the 5′-upstream regulatory region of the Ca2+-release channel gene of cardiac sarcoplasmic reticulum. Eur. J. Biochem.
240:408–415. 10.1111/j.1432-1033.1996.0408h.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1432-1033.1996.0408h.x</ArticleId>
            <ArticleId IdType="pubmed">8841406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Opthof, T., Coronel R., Rademaker H.M., Vermeulen J.T., Wilms-Schopman F.J., and Janse M.J.. 2000. Changes in sinus node function in a rabbit model of heart failure with ventricular arrhythmias and sudden death. Circulation. 101:2975–2980. 10.1161/01.cir.101.25.2975</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.cir.101.25.2975</ArticleId>
            <ArticleId IdType="pubmed">10869272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prunier, F., Chen Y., Gellen B., Heimburger M., Choqueux C., Escoubet B., Michel J.B., and Mercadier J.J.. 2005. Left ventricular SERCA2a gene down-regulation does not parallel ANP gene up-regulation during post-MI remodelling in rats. Eur. J. Heart Fail.
7:739–747. 10.1016/j.ejheart.2004.10.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejheart.2004.10.007</ArticleId>
            <ArticleId IdType="pubmed">16087130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenberg, A.A., Weiser-Bitoun I., Billman G.E., and Yaniv Y.. 2020. Signatures of the autonomic nervous system and the heart’s pacemaker cells in canine electrocardiograms and their applications to humans. Sci. Rep.
10:9971. 10.1038/s41598-020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020</ArticleId>
            <ArticleId IdType="pmc">PMC7305326</ArticleId>
            <ArticleId IdType="pubmed">32561798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Said, M., Mundina-Weilenmann C., Vittone L., and Mattiazzi A.. 2002. The relative relevance of phosphorylation of the Thr(17) residue of phospholamban is different at different levels of beta-adrenergic stimulation. Pflugers Arch.
444:801–809. 10.1007/s00424-002s0040885-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00424-002s0040885-y</ArticleId>
            <ArticleId IdType="pubmed">12355181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanders, P., Kistler P.M., Morton J.B., Spence S.J., and Kalman J.M.. 2004. Remodeling of sinus node function in patients with congestive heart failure: Reduction in sinus node reserve. Circulation. 110:897–903. 10.1161/01.CIR.0000139336.69955.AB</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.0000139336.69955.AB</ArticleId>
            <ArticleId IdType="pubmed">15302799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shinohara, T., Park H.W., Han S., Shen M.J., Maruyama M., Kim D., Chen P.S., and Lin S.F.. 2010. Ca2+ clock malfunction in a canine model of pacing-induced heart failure. Am. J. Physiol. Heart Circ. Physiol.
299:H1805–H1811. 10.1152/ajpheart.00723.2010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00723.2010</ArticleId>
            <ArticleId IdType="pmc">PMC3006277</ArticleId>
            <ArticleId IdType="pubmed">20889842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stevenson, W.G., Stevenson L.W., Middlekauff H.R., and Saxon L.A.. 1993. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 88:2953–2961. 10.1161/01.cir.88.6.2953</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.cir.88.6.2953</ArticleId>
            <ArticleId IdType="pubmed">8252708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swaminathan, P.D., Purohit A., Hund T.J., and Anderson M.E.. 2012. Calmodulin-dependent protein kinase II: Linking heart failure and arrhythmias. Circ. Res.
110:1661–1677. 10.1161/circresaha.111.243956</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/circresaha.111.243956</ArticleId>
            <ArticleId IdType="pmc">PMC3789535</ArticleId>
            <ArticleId IdType="pubmed">22679140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uretsky, B.F., and Sheahan R.G.. 1997. Primary prevention of sudden cardiac death in heart failure: Will the solution be shocking?
J. Am. Coll. Cardiol.
30:1589–1597. 10.1016/s0735-1097(97)00361-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0735-1097(97)00361-6</ArticleId>
            <ArticleId IdType="pubmed">9385881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vatner, S.F., Higgins C.B., and Braunwald E.. 1974. Sympathetic and parasympathetic components of reflex tachycardia induced by hypotension in conscious dogs with and without heart failure. Cardiovasc. Res.
8:153–161. 10.1093/cvr/8.2.153</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cvr/8.2.153</ArticleId>
            <ArticleId IdType="pubmed">4207176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vedantham, V., Evangelista M., Huang Y., and Srivastava D.. 2013. Spatiotemporal regulation of an Hcn4 enhancer defines a role for Mef2c and HDACs in cardiac electrical patterning. Dev. Biol.
373:149–162. 10.1016/j.ydbio.2012.10.017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2012.10.017</ArticleId>
            <ArticleId IdType="pmc">PMC3510001</ArticleId>
            <ArticleId IdType="pubmed">23085412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verkerk, A.O., van Borren M.M., van Ginneken A.C., and Wilders R.. 2015. Ca2+ cycling properties are conserved despite bradycardic effects of heart failure in sinoatrial node cells. Front. Physiol.
6:18. 10.3389/fphys.2015.00018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2015.00018</ArticleId>
            <ArticleId IdType="pmc">PMC4313601</ArticleId>
            <ArticleId IdType="pubmed">25698973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verkerk, A.O., Wilders R., Coronel R., Ravesloot J.H., and Verheijck E.E.. 2003. Ionic remodeling of sinoatrial node cells by heart failure. Circulation. 108:760–766. 10.1161/01.CIR.0000083719.51661.B9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.0000083719.51661.B9</ArticleId>
            <ArticleId IdType="pubmed">12885752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinet, L., Rouet-Benzineb P., Marniquet X., Pellegrin N., Mangin L., Louedec L., Samuel J.L., and Mercadier J.J.. 2008. Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction. Am. J. Physiol. Heart Circ. Physiol.
295:H352–H360. 10.1152/ajpheart.01101.2007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.01101.2007</ArticleId>
            <ArticleId IdType="pubmed">18487442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinogradova, T.M., Zhou Y.Y., Bogdanov K.Y., Yang D., Kuschel M., Cheng H., and Xiao R.P.. 2000. Sinoatrial node pacemaker activity requires Ca2+/calmodulin-dependent protein kinase II activation. Circ. Res.
87:760–767. 10.1161/01.res.87.9.760</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.res.87.9.760</ArticleId>
            <ArticleId IdType="pubmed">11055979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang, Y.Y., Mesirca P., Marques-Sule E., Zahradnikova A. Jr., Villejoubert O., D’Ocon P., Ruiz C., Domingo D., Zorio E., Mangoni M.E., et al. . 2017. RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism. JCI Insight. 2:91872. 10.1172/jci.insight.91872</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/jci.insight.91872</ArticleId>
            <ArticleId IdType="pmc">PMC5396513</ArticleId>
            <ArticleId IdType="pubmed">28422759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weber, K.T., Kinasewitz G.T., Janicki J.S., and Fishman A.P.. 1982. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation. 65:1213–1223. 10.1161/01.cir.65.6.1213</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.cir.65.6.1213</ArticleId>
            <ArticleId IdType="pubmed">6804111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu, Y., and Anderson M.E.. 2014. CaMKII in sinoatrial node physiology and dysfunction. Front. Pharmacol.
5:48. 10.3389/fphar.2014.00048</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2014.00048</ArticleId>
            <ArticleId IdType="pmc">PMC3957193</ArticleId>
            <ArticleId IdType="pubmed">24672485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu, Y., Gao Z., Chen B., Koval O.M., Singh M.V., Guan X., Hund T.J., Kutschke W., Sarma S., Grumbach I.M., et al. . 2009. Calmodulin kinase II is required for fight or flight sinoatrial node physiology. Proc. Natl. Acad. Sci. USA. 106:5972–5977. 10.1073/pnas.0806422106</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0806422106</ArticleId>
            <ArticleId IdType="pmc">PMC2667018</ArticleId>
            <ArticleId IdType="pubmed">19276108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yaniv, Y., Lakatta E.G., and Maltsev V.A.. 2015. From two competing oscillators to one coupled-clock pacemaker cell system. Front. Physiol.
6:28. 10.3389/fphys.2015.00028</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2015.00028</ArticleId>
            <ArticleId IdType="pmc">PMC4327306</ArticleId>
            <ArticleId IdType="pubmed">25741284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yaniv, Y., Sirenko S., Ziman B.D., Spurgeon H.A., Maltsev V.A., and Lakatta E.G.. 2013. New evidence for coupled clock regulation of the normal automaticity of sinoatrial nodal pacemaker cells: Bradycardic effects of ivabradine are linked to suppression of intracellular Ca2+ cycling. J. Mol. Cell Cardiol.
62:80–89. 10.1016/j.yjmcc.2013.04.026</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yjmcc.2013.04.026</ArticleId>
            <ArticleId IdType="pmc">PMC3735682</ArticleId>
            <ArticleId IdType="pubmed">23651631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yanni, J., D’Souza A., Wang Y., Li N., Hansen B.J., Zakharkin S.O., Smith M., Hayward C., Whitson B.A., Mohler P.J., et al. . 2020. Silencing miR-370-3p rescues funny current and sinus node function in heart failure. Sci. Rep.
10:11279. 10.1038/s41598-020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020</ArticleId>
            <ArticleId IdType="pmc">PMC7347645</ArticleId>
            <ArticleId IdType="pubmed">32647133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin, L., Zahradnikova A. Jr., Rizzetto R., Boncompagni S., Rabesahala de Meritens C., Zhang Y., Joanne P., Marques-Sule E., Aguilar-Sanchez Y., Fernandez-Tenorio M., et al. . 2021. Impaired binding to junctophilin-2 and nanostructural alteration in CPVT mutation. Circ. Res.
129:e35–e52. 10.1161/CIRCRESAHA.121.319094</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319094</ArticleId>
            <ArticleId IdType="pmc">PMC8320243</ArticleId>
            <ArticleId IdType="pubmed">34111951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang, R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., Price E.E. Jr., Thiel W., Guatimosim S., Song L.S., et al. . 2005. Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med.
11:409–417. 10.1038/nm1215</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1215</ArticleId>
            <ArticleId IdType="pubmed">15793582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zicha, S., Fernandez-Velasco M., Lonardo G., L’Heureux N., and Nattel S.. 2005. Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model. Cardiovasc. Res.
66:472–481. 10.1016/j.cardiores.2005.02.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cardiores.2005.02.011</ArticleId>
            <ArticleId IdType="pubmed">15914112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zweerink, A., van der Lingen A.C.J., Handoko M.L., van Rossum A.C., and Allaart C.P.. 2018. Chronotropic incompetence in chronic heart failure. Circ. Heart Fail.
11:e004969. 10.1161/CIRCHEARTFAILURE.118.004969</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.118.004969</ArticleId>
            <ArticleId IdType="pubmed">30354566</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
